Journal Watch · Science Advances · 2026
<i>C. elegans</i> somatostatin/allatostatin C signaling regulates sleep, metabolism, survival, and memory via a sleep-active neuron.
A similar somatostatin-mediated regulation of sleep neurons may underlie physiological regulation in other species.
TL;DR
A similar somatostatin-mediated regulation of sleep neurons may underlie physiological regulation in other species.
Key findings
- Both NLP-99/NPR-16 and RIS/FLP-11 are required for memory consolidation.
- These results show that NLP-99/NPR-16 regulates physiological processes via control of RIS.
- A similar somatostatin-mediated regulation of sleep neurons may underlie physiological regulation in other species.
What they did
NPR-16 is G<sub>i/o</sub> coupled and acts cell nonautonomously to activate the sleep-active RIS neuron while acting autonomously in RIS to inhibit calcium activation and the release of the sleep-inducing FLP-11 neuropeptides. During larval arrest, strong NPR-16 expression in RIS causes NLP-99/NPR-16 signaling to inhibit sleep, reducing lipid storage and survival. In well-fed adults, NPR-16 expression is stronger outside of RIS, and NLP-99/NPR-16 signaling is required for RIS activation and sleep while also inhibiting longevity via RIS.
Full abstract (original)
Background: Somatostatin/allatostatin C signaling regulates sleep, metabolism, memory, and longevity, but the underlying neuronal mechanisms remain unclear. We investigated the <i>Caenorhabditis elegans</i> somatostatin/allatostatin C ortholog NLP-99 and its receptor NPR-16. We found that the wake-active AIY neurons release NLP-99 to activate NPR-16.
What they did: NPR-16 is G<sub>i/o</sub> coupled and acts cell nonautonomously to activate the sleep-active RIS neuron while acting autonomously in RIS to inhibit calcium activation and the release of the sleep-inducing FLP-11 neuropeptides. During larval arrest, strong NPR-16 expression in RIS causes NLP-99/NPR-16 signaling to inhibit sleep, reducing lipid storage and survival. In well-fed adults, NPR-16 expression is stronger outside of RIS, and NLP-99/NPR-16 signaling is required for RIS activation and sleep while also inhibiting longevity via RIS.
Results & conclusions: Both NLP-99/NPR-16 and RIS/FLP-11 are required for memory consolidation. These results show that NLP-99/NPR-16 regulates physiological processes via control of RIS. A similar somatostatin-mediated regulation of sleep neurons may underlie physiological regulation in other species.
Abstract © the authors / Science Advances (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1126/sciadv.adv8387 · PubMed 41984956.
Why it matters for pharma & biotech
- Relevant to General & Medicine teams tracking Science Advances for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Science Advances study find?
A similar somatostatin-mediated regulation of sleep neurons may underlie physiological regulation in other species.
What type of study is this?
It is a preclinical (animal / model) study, published in Science Advances in 2026. NPR-16 is G<sub>i/o</sub> coupled and acts cell nonautonomously to activate the sleep-active RIS neuron while acting autonomously in RIS to inhibit calcium activation and the release of the sleep-inducing FLP-11 neuropeptides.
Where can I read the original paper?
The original is at the publisher via DOI 10.1126/sciadv.adv8387. PubMed ID: 41984956. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/lt-i-gt-c-elegans-lt-i-gt-somatostatin-allatostatin-c-signaling-regulate-dv8387/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides